NMN can raise NAD-related blood measures in several human trials, but that is not the same as showing longer life, younger-looking skin, more energy, or better hearing. The useful question is which outcome a study actually measured. In a University of Michigan poll, 78% of adults ages 50 to 80 reported taking a dietary supplement in a typical week, which makes a clear pills-and-supplements checklist worth having before you add one more item to your routine.
For NMN, the human results are mixed by outcome. Some trials found higher NAD-related measures and selected walking or quality-of-life signals. Others found no benefit on their main outcome. If persistent tiredness, hearing problems, confusion, falls, or a medical condition is driving your decision, contact a provider soon instead of treating NMN as the answer.
What NMN studies have measured so far
| Question you may have | What human studies measured | What the result means |
|---|---|---|
| NAD biomarkers | Several trials measured blood NAD or related metabolites. | Raised measures were reported. This does not by itself establish a daily-life benefit. |
| Fatigue | A 2026 pooled analysis included 16 studies and 1,126 people. | No significant pooled fatigue benefit was found; the estimate crossed no effect. |
| Sleep | Some trials used sleep questionnaires. | Selected results appeared in individual studies, but pooled sleep benefit is not established. |
| Metabolic outcomes | Trials measured insulin resistance, lipids, body composition, and related measures. | Results differ by study; a 60-day trial found no between-group HOMA-IR difference. |
| Exercise and function | Studies used stepping, four-meter walking, and six-minute walking tests. | Some secondary measures improved, while primary outcomes did not always improve. |
| Hearing | A 24-week trial used pure-tone hearing thresholds as its primary outcome. | Benefit was not demonstrated. |
| Lifespan or looking younger | The human trials described here did not measure lifespan or a change in appearance. | Not established. |
A blood marker can be important research, but it is not automatically a result you can feel at home. Our surrogate outcomes guide explains why a number in a lab test and a patient benefit need to be kept separate.
What did the September 2026 NMN trial find?
The newest trial followed healthy Japanese adults age 65 and older for 24 weeks. It was randomized, double-blind, and placebo-controlled. The group taking NMN had higher blood NAD and related metabolites.
Its prespecified main outcome was pure-tone hearing. The trial did not show a significant hearing improvement. It also did not show physical-performance benefit. Some body-composition, lipid, and diet findings appeared before the researchers corrected for multiple testing, but did not remain significant afterward. You can read the full 24-week hearing trial for the study design and results.
That comparison matters if an ad makes a broad promise from a higher NAD number. In this study, the biomarker changed while the main hearing result did not. It does not answer whether NMN will help a particular person's tiredness, hearing concern, stairs, or safety at home.
How do the earlier NMN trials compare?
Earlier trials asked different questions in different groups. That is why one headline cannot answer every NMN benefits question.
| Study | Who and how long | Main measure | Reported result |
|---|---|---|---|
| Older adults, 2024 | 60 older adults; 12 weeks; placebo-controlled. | Stepping test. | The primary stepping result did not differ. Secondary four-meter walking time and blood NAD-related measures favored NMN. |
| Healthy middle-aged adults, 2023 | 80 adults; 60 days; placebo and three NMN groups. | Blood NAD concentration. | Blood NAD rose. Six-minute walking and SF-36 were secondary measures; HOMA-IR did not differ between groups. |
| Older Japanese adults, 2026 | Healthy adults age 65 and older; 24 weeks; placebo-controlled. | Pure-tone hearing thresholds. | NAD-related metabolites increased, but hearing and physical-performance benefits were not demonstrated. |
The older-adult walking trial is a good example of why primary and secondary outcomes should stay in separate boxes. Its primary stepping test did not differ between groups, even though a secondary walking measure did. The middle-aged adult trial also found higher blood NAD over 60 days, while its insulin-resistance measure did not differ between groups.
One earlier study in postmenopausal women with prediabetes who were overweight or obese reported metabolic and muscle findings after 10 weeks. That is a selected population, not a reason to carry its result over to healthy adults, men, or people seeking an anti-aging supplement.
What about tiredness, sleep, cholesterol, strength, and appearance?
A 2026 systematic review and network meta-analysis combined studies of several NAD precursors, not NMN alone. Across 16 studies and 1,126 people, its fatigue estimate crossed no effect. It also found no overall sleep benefit. This is useful context, but it is a secondary synthesis rather than a new NMN trial, and it combined healthy and clinical populations with different measures and follow-up periods. Read the 2026 pooled analysis for its methods and outcome groups.
The 2026 hearing trial reported exploratory lipid-related findings that did not remain significant after correction for multiple testing. That does not establish that NMN lowers cholesterol. The available human trials described here also do not establish that NMN makes you look younger, changes testosterone, causes weight loss, prevents falls, or extends lifespan.
For daily support that does not depend on a supplement claim, our Care Team's prevention at home guide can help you think through routines and safety at home. If your goal is better sleep or recovery, start by naming the specific outcome you want to track rather than relying on a broad “more energy” promise.
Why can two NMN headlines sound so different?
Placebo groups matter because people can report change even when they did not receive the active product. A primary outcome is the main question a trial planned to answer. Secondary outcomes can be useful, but they need more care because a study may measure many of them.
Subgroup findings can also be worth studying without becoming a promise for everyone else. Check each paper's funding and conflict-of-interest statement when you read it.
What are the downsides and side effects of NMN?
In the 60-day trial of healthy middle-aged adults, researchers reported no safety issues from monitored adverse events, laboratory measures, and clinical measures. The 24-week study said high-dose NMN was generally well tolerated and reported no significant adverse effects, while also saying careful safety monitoring is warranted. These studies cannot establish rare or long-term harms.
NMN adds another supplement to an often crowded list of pills. The University of Michigan poll advises bringing a complete list of prescription medicines, over-the-counter medicines, and supplements to appointments, or bringing the products themselves. That is especially useful when you are sorting out what belongs in your routine. For a broader decision about supplements, see when to consider a supplement.
How many milligrams of NMN do you need?
The studies used different amounts for different research questions. The 2024 older-adult walking trial used 250 mg daily for 12 weeks. The 2023 healthy middle-aged trial studied 300 mg, 600 mg, and 900 mg daily for 60 days. The 2026 hearing trial studied 1,250 mg daily for 24 weeks. Those are study details, not a personal dose plan or proof that one amount is right for you.
What did this longevity study actually show?
Keep the study result next to the claim you are evaluating. This prevents an impressive headline from answering a question the study never tested.
- Find the original paper or registry entry. Record whether it is a protocol, animal experiment, observational study, or completed human trial. A planned study has no completed result to report.
- Identify the participants, intervention, comparator, duration, and main measured outcome. Note the number enrolled and analyzed when available. Keep blood markers, symptoms, function, and lifespan in separate rows.
- Copy the result accurately in your own words, including uncertainty and harms reported. Look for the size of the difference, not only whether a result is called statistically significant. Record funding and major limitations.
- Ask how closely the participants and intervention match the question you care about. Use “not measured,” “not reported,” or “unclear” when appropriate. Those answers are more useful than filling a gap with an assumption.
Claim being checked: ____________________
Paper or registry and date: ____________________
Study type: ____________________
Population and duration: ____________________
| Outcome | How measured | Reported result | Limit or uncertainty | What it cannot establish |
|---|---|---|---|---|
Illustration only: a trial measures a blood metabolite before and after a product. If it does not measure stair climbing or lifespan, mark those outcomes “not measured.” A positive biomarker result cannot fill the empty rows.
This reading aid is not a systematic review or personal treatment recommendation. A single study may need to be interpreted alongside other research and expert guidance.
Before you add NMN to your supplement list
- Write down the one outcome you hope to improve: fatigue, walking, sleep, hearing, appearance, or something else.
- Ask whether the product label states the ingredient amount and serving directions clearly.
- Put NMN beside every prescription medicine, over-the-counter medicine, and supplement you use, then ask a pharmacist what needs checking.
- Ask the seller for today's price, bundle terms, cancellation steps, and refund terms before ordering. Prices and bundles change.
- Keep your goal separate from a lab marker. If the study did not measure your goal, write “not measured.”
For many people, the best next step is no purchase yet: use the worksheet, then take your complete medicines and supplements list to a clinician or pharmacist. If your main goal is staying steady in familiar surroundings, our home-based care guide offers another practical starting point.
Disclosure: Senior Safety Desk may earn a commission if you use links to products or services. This does not change what you pay.
By the Senior Safety Desk Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.